Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Core Insights - Adicet Bio, Inc. has granted an inducement award to a new employee, which includes stock options for 84,000 shares at an exercise price of $1.89 per share, reflecting the closing price on December 29, 2023 [2] - The stock options will vest over a four-year period, with one-fourth vesting on the one-year anniversary and the remaining shares vesting in equal monthly installments [2] - The award was granted outside of the company's stockholder-approved equity incentive plans, under the 2022 Inducement Plan, and was authorized by the compensation committee of the board of directors [3] Company Overview - Adicet Bio, Inc. is a clinical stage biotechnology company focused on developing allogeneic gamma delta T cell therapies for cancer [4] - The company is advancing a pipeline of engineered gamma delta T cells with chimeric antigen receptors (CARs) aimed at enhancing tumor targeting and promoting anti-tumor immune responses [4]